Marie Kouamenan
Payments from drug & device makers
Across 231 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$987
- Boehringer Ingelheim$505
- United Therapeutics Corporation$500
- Actelion Pharmaceuticals US, Inc.$299
- Astellas Pharma US Inc$256
- AstraZeneca$233
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,73996%
- Education$1694%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 69 | $987 |
| Boehringer Ingelheim | 25 | $505 |
| United Therapeutics Corporation | 32 | $500 |
| Actelion Pharmaceuticals US, Inc. | 19 | $299 |
| Astellas Pharma US Inc | 8 | $256 |
| AstraZeneca | 14 | $233 |
| Merck | 14 | $229 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $141 |
| Mylan Specialty L.p. | 8 | $132 |
| Bayer | 8 | $118 |
| Viatris Specialty LLC | 5 | $101 |
| Abiomed | 1 | $42 |
| Bridgebio Pharma, Inc. | 2 | $38 |
| Vifor Pharma, Inc. | 2 | $34 |
| AbbVie | 1 | $34 |
| Kamada Ltd. | 1 | $33 |
| Insmed, Inc. | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 2 | $30 |
| Atricure, Inc. | 1 | $30 |
| La Jolla Pharmaceutical Company | 1 | $24 |
| Dexcom, Inc. | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Sanofi | 1 | $15 |
| Harmony Biosciences LLC | 1 | $15 |
| Amgen | 1 | $14 |
| ANI Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OFEV$102
How this compares
$3,908 in reported general payments places this provider in the 90th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Voriconazole | 17 | $13,560 |
| Tacrolimus | 56 | $5,930 |
| Valganciclovir Hcl | 33 | $5,192 |
| Dapsone | 29 | $2,068 |
| Mycophenolate Mofetil | 19 | $822 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $753 |
| Prednisone | 78 | $434 |
| Pantoprazole Sodium | 70 | $348 |
| Azithromycin | 56 | $281 |
| Pravastatin Sodium | 63 | $261 |
| Metoprolol Tartrate | 38 | $228 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 67 | $192 |
| Acyclovir | 13 | $169 |
| Tamsulosin Hcl | 15 | $125 |
| Metoclopramide Hcl | 21 | $122 |
Paid to pharmacies, not to this prescriber.
Other family in Bronx
- Vladimir ByhovskyBronx$70K
- May YuBronx$24K
- Daphenie FauvelBronx$21K
- Schevaughn Carr CelestineBronx$20K
- Nighat SaeedBronx$19K
- Keisha BallentineBronx$18K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.